AG
MGNX icon

Algert Global’s MacroGenics MGNX Stock Holding History

Algert Global’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-88,130
Closed -$148K – 1255
2025
Q3 		$148K Buy
+88,130
New +$143K ﹤0.01% 1065
2022
Q2 		– Sell
-24,806
Closed -$219K – 1315
2022
Q1 		$219K Buy
+24,806
New +$274K 0.01% 1029
2019
Q3 		– Sell
-12,105
Closed -$205K – 407
2019
Q2 		$205K Sell
12,105
-8,687
-42% -$149K 0.08% 273
2019
Q1 		$374K Sell
20,792
-18,548
-47% -$321K 0.21% 158
2018
Q4 		$500K Buy
39,340
+29,531
+301% +$495K 0.14% 223
2018
Q3 		$210K Hold
9,809
– – 0.05% 322
2018
Q2 		$203K Buy
+9,809
New +$221K 0.04% 310

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Algert Global's MGNX Position: Q4 2025 in Review

Algert Global sold out of MacroGenics (MGNX) in Q4 2025, closing a stake of 88,130 shares — an estimated $148K sold.

Algert Global first reported a position in MGNX in Q2 2018 and held it in 7 quarters. The position peaked at $500K in Q4 2018. 88 funds tracked by Wall St. Rank hold MGNX as of Q4 2025.

  • Algert Global reported no remaining MacroGenics position as of Q4 2025 after selling out during the quarter.
  • Algert Global sold 88,130 MacroGenics shares in Q4 2025, an estimated $148K.
  • Algert Global first reported a position in MacroGenics in Q2 2018 and held it in 7 quarters.
  • Algert Global's MacroGenics position peaked at $500K in Q4 2018.
  • 88 funds tracked by Wall St. Rank held MacroGenics as of Q4 2025.

Based on Algert Global's 13F filing for Q4 2025, filed 17 Feb 2026.